MA37691A1 - 5-amino[1,4]thiazines comme inhibiteurs de bace1 - Google Patents
5-amino[1,4]thiazines comme inhibiteurs de bace1Info
- Publication number
- MA37691A1 MA37691A1 MA37691A MA37691A MA37691A1 MA 37691 A1 MA37691 A1 MA 37691A1 MA 37691 A MA37691 A MA 37691A MA 37691 A MA37691 A MA 37691A MA 37691 A1 MA37691 A1 MA 37691A1
- Authority
- MA
- Morocco
- Prior art keywords
- thiazines
- amino
- bace1 inhibitors
- present
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La présente invention concerne des composés de formule i présentant une activité inhibitrice de bace1, leur préparation, des compositions pharmaceutiques les contenant et leur utilisation comme substances thérapeutiquement actives. Les composés actifs de la présente invention sont utiles dans le traitement thérapeutique et/ou prophylactique de, par exemple, la maladie d'alzheimer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12169353 | 2012-05-24 | ||
PCT/EP2013/060352 WO2013174781A1 (fr) | 2012-05-24 | 2013-05-21 | 5-amino[1,4]thiazines comme inhibiteurs de bace1 |
Publications (2)
Publication Number | Publication Date |
---|---|
MA37691A1 true MA37691A1 (fr) | 2016-03-31 |
MA37691B1 MA37691B1 (fr) | 2016-11-30 |
Family
ID=48534350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA37691A MA37691B1 (fr) | 2012-05-24 | 2014-12-24 | 5-amino[1,4]thiazines comme inhibiteurs de bace1 |
Country Status (22)
Country | Link |
---|---|
US (1) | US9273042B2 (fr) |
EP (1) | EP2855469B1 (fr) |
JP (1) | JP6251249B2 (fr) |
KR (1) | KR20150014934A (fr) |
CN (1) | CN104334554B (fr) |
AU (1) | AU2013265376B2 (fr) |
BR (1) | BR112014028813A2 (fr) |
CA (1) | CA2872179A1 (fr) |
CL (1) | CL2014003123A1 (fr) |
CO (1) | CO7131369A2 (fr) |
CR (1) | CR20140495A (fr) |
EA (1) | EA026004B1 (fr) |
HK (1) | HK1201261A1 (fr) |
IL (1) | IL235681A (fr) |
MA (1) | MA37691B1 (fr) |
MX (1) | MX2014013839A (fr) |
NZ (1) | NZ702254A (fr) |
PE (1) | PE20150021A1 (fr) |
PH (1) | PH12014502541B1 (fr) |
SG (1) | SG11201407575PA (fr) |
UA (1) | UA113438C2 (fr) |
WO (1) | WO2013174781A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014524472A (ja) * | 2011-08-22 | 2014-09-22 | メルク・シャープ・アンド・ドーム・コーポレーション | Bace阻害剤としての2−スピロ置換イミノチアジンならびにそのモノオキシドおよびジオキシド、組成物、ならびにそれらの使用 |
WO2014059185A1 (fr) | 2012-10-12 | 2014-04-17 | Amgen Inc. | Composés amino-dihydrothiazine et amino-dioxydo dihydrothiazine en tant qu'antagonistes de bêta-sécrétase et procédés d'utilisation |
WO2015017407A1 (fr) | 2013-07-30 | 2015-02-05 | Amgen Inc. | Composés de dioxyde d'amino-thiazine bicycliques pontés en tant qu'inhibiteurs de bêta-sécrétase |
WO2015038446A1 (fr) * | 2013-09-13 | 2015-03-19 | Merck Sharp & Dohme Corp. | Dioxydes d'iminothiazine spiro-c5 utilisés comme inhibiteurs de bace, compositions, et leur utilisation |
US9920072B2 (en) | 2014-11-03 | 2018-03-20 | Hoffmann-La Roche Inc. | BACE1 inhibitors |
WO2016150785A1 (fr) | 2015-03-20 | 2016-09-29 | F. Hoffmann-La Roche Ag | Inhibiteurs de bace1 |
JP6895424B2 (ja) * | 2015-08-12 | 2021-06-30 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Bace1阻害剤 |
AU2019258575A1 (en) | 2018-04-27 | 2020-10-29 | Shionogi & Co., Ltd. | Tetrahydropyranooxazine derivatives having selective BACE1 inhibitory activity |
CN110467611B (zh) * | 2018-05-11 | 2022-09-27 | 广东东阳光药业有限公司 | 亚氨基噻二嗪二氧化物衍生物及其用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008516945A (ja) * | 2004-10-15 | 2008-05-22 | アストラゼネカ・アクチエボラーグ | 置換されたアミノ化合物およびそれらの使用 |
US8461160B2 (en) * | 2009-05-08 | 2013-06-11 | Hoffmann-La Roche, Inc. | Dihydropyrimidinones |
US8188079B2 (en) | 2009-08-19 | 2012-05-29 | Hoffman-La Roche Inc. | 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines |
US20110065695A1 (en) * | 2009-09-11 | 2011-03-17 | Jeremy Beauchamp | Use of aminodihydrothiazines for the treatment or prevention of diabetes |
UA103272C2 (uk) | 2009-12-11 | 2013-09-25 | Ф. Хоффманн-Ля Рош Аг | 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2 |
US9499502B2 (en) * | 2011-04-13 | 2016-11-22 | Merck Sharp & Dohme Corp. | 5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use |
JP2014524472A (ja) * | 2011-08-22 | 2014-09-22 | メルク・シャープ・アンド・ドーム・コーポレーション | Bace阻害剤としての2−スピロ置換イミノチアジンならびにそのモノオキシドおよびジオキシド、組成物、ならびにそれらの使用 |
-
2013
- 2013-05-21 UA UAA201413535A patent/UA113438C2/uk unknown
- 2013-05-21 SG SG11201407575PA patent/SG11201407575PA/en unknown
- 2013-05-21 NZ NZ702254A patent/NZ702254A/en not_active IP Right Cessation
- 2013-05-21 BR BR112014028813A patent/BR112014028813A2/pt not_active IP Right Cessation
- 2013-05-21 AU AU2013265376A patent/AU2013265376B2/en not_active Ceased
- 2013-05-21 JP JP2015513132A patent/JP6251249B2/ja not_active Expired - Fee Related
- 2013-05-21 CN CN201380026707.3A patent/CN104334554B/zh not_active Expired - Fee Related
- 2013-05-21 KR KR1020147032555A patent/KR20150014934A/ko not_active Application Discontinuation
- 2013-05-21 EP EP13725321.7A patent/EP2855469B1/fr active Active
- 2013-05-21 MX MX2014013839A patent/MX2014013839A/es unknown
- 2013-05-21 WO PCT/EP2013/060352 patent/WO2013174781A1/fr active Application Filing
- 2013-05-21 EA EA201492097A patent/EA026004B1/ru not_active IP Right Cessation
- 2013-05-21 PE PE2014002013A patent/PE20150021A1/es not_active Application Discontinuation
- 2013-05-21 CA CA2872179A patent/CA2872179A1/fr not_active Abandoned
- 2013-05-21 US US14/400,448 patent/US9273042B2/en not_active Expired - Fee Related
-
2014
- 2014-10-27 CR CR20140495A patent/CR20140495A/es unknown
- 2014-11-11 CO CO14249385A patent/CO7131369A2/es unknown
- 2014-11-13 IL IL235681A patent/IL235681A/en not_active IP Right Cessation
- 2014-11-14 PH PH12014502541A patent/PH12014502541B1/en unknown
- 2014-11-18 CL CL2014003123A patent/CL2014003123A1/es unknown
- 2014-12-24 MA MA37691A patent/MA37691B1/fr unknown
-
2015
- 2015-02-17 HK HK15101737.9A patent/HK1201261A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL235681A0 (en) | 2015-02-01 |
KR20150014934A (ko) | 2015-02-09 |
IL235681A (en) | 2017-10-31 |
CR20140495A (es) | 2014-12-01 |
US9273042B2 (en) | 2016-03-01 |
EA201492097A1 (ru) | 2015-04-30 |
MX2014013839A (es) | 2015-02-04 |
BR112014028813A2 (pt) | 2017-06-27 |
PH12014502541A1 (en) | 2015-01-21 |
CA2872179A1 (fr) | 2013-11-28 |
CO7131369A2 (es) | 2014-12-01 |
PE20150021A1 (es) | 2015-01-28 |
MA37691B1 (fr) | 2016-11-30 |
EA026004B1 (ru) | 2017-02-28 |
HK1201261A1 (en) | 2015-08-28 |
EP2855469A1 (fr) | 2015-04-08 |
NZ702254A (en) | 2016-08-26 |
CN104334554A (zh) | 2015-02-04 |
WO2013174781A1 (fr) | 2013-11-28 |
EP2855469B1 (fr) | 2019-06-19 |
PH12014502541B1 (en) | 2015-01-21 |
AU2013265376A1 (en) | 2014-11-13 |
US20150141413A1 (en) | 2015-05-21 |
CN104334554B (zh) | 2017-10-31 |
UA113438C2 (xx) | 2017-01-25 |
SG11201407575PA (en) | 2014-12-30 |
CL2014003123A1 (es) | 2015-02-27 |
AU2013265376B2 (en) | 2017-07-20 |
JP6251249B2 (ja) | 2017-12-20 |
JP2015517548A (ja) | 2015-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA37691B1 (fr) | 5-amino[1,4]thiazines comme inhibiteurs de bace1 | |
MA35193B1 (fr) | Halogeno-alkyl-1,3 oxazines en tant qu'inhibiteurs de bace1 et/ou bace2 | |
MA35748B1 (fr) | Fluorométhyl-5,6-dihydro-4h-[1,3]oxazines | |
MA35246B1 (fr) | 1,3-oxazines en tant qu'inhibiteurs de bace1 et/ou de bace2 | |
MA35191B1 (fr) | Spiro-[1,3]-oxazines et spiro-[1,4]-oxazepines en tant qu'inhibiteurs de baec1 et/ou bace2 | |
MA38556A1 (fr) | Inhibiteurs de bace1 | |
MA37763A1 (fr) | Difluoro-hexahydro-cyclopentaoxazinyles et difluoro-hexahydro-benzooxazinyles en tant qu'inhibiteurs de bace1 | |
MA38380A1 (fr) | Inhibiteurs quinazoline de l'activation des formes mutantes du récepteur de croissance épidermique (egfr) | |
MA35114B1 (fr) | 1,3-oxazines à titre d'inhibiteurs de bace1 et/ou de bace2 | |
MA42295B1 (fr) | Composés de la benzoxazépin oxazolidinone et procédé pour leur utilisation | |
MX2013007558A (es) | 1,4-oxazinas como inhibidores de los genes enzima de segmentacion de la proteina precursora del sitio 1 y/o 2 (bace1 y/o bace2). | |
MX2013007957A (es) | 1,4-oxazinas como inhibidores de los genes de enzima de segmentacion de la proteina precursora amiloide del sitio beta 1 y/o (bace1 y/o bace2). | |
MA33239B1 (fr) | 3h-imidazo [4,5-c] pyridine-6-carboxamides en tant qu'anti-inflammatoires | |
MA35576B1 (fr) | Nouveaux composés | |
BR112015016315A2 (pt) | fluoro-[1,3]oxazinas como inibidores de bace1 | |
MA41179A (fr) | Composés inhibiteurs de parg | |
MX2013008478A (es) | 1, 4 riazepinas/sulfonas como inhibidores de beta secretasa 1 (base1) y/o beta secretasa 2 (bace2). | |
BR112014006763A2 (pt) | n-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexa-hidro-ciclopenta[e][1,3]oxazin-4-il)-fenil)-amidas como inibidores de bace1 | |
MX2013014194A (es) | 1,3-tiazepinas fusionadas a ciclopropilo como inhibidores de beta-secretasa 1 (bace) y/o beta-secretasa 2 (bace 2). | |
MA52370B1 (fr) | Dérivés de la pyridine et leurs utilisations thérapeutiques comme inhibiteurs du trpc6 | |
MA38473B1 (fr) | (benzyl-cyano-méthyl)-amides substitués de l'acide 2-aza-bicyclo[2.2.1]heptane-3-carboxylique utilisés comme inhibiteurs de la cathépsine c | |
MA39260A1 (fr) | (benzyl-cyano-méthyl)-amides substitués de l'acide 2-aza-bicyclo[2.2.1]heptane-3-carboxylique utilisés comme inhibiteurs de la cathépsine c | |
MA38280B1 (fr) | Composes 1,2,3,4-tetrahydroisoquinoleine substitues inhibiteurs de la proteine arginine-methyltransferase 5 | |
FR3012811B1 (fr) | Oligopeptides et leurs utilisations | |
MA38057B1 (fr) | Inhibiteurs d'histone déméthylases |